Studies suggest that around 10–40% of patients undergoing solid organ tranplantation develop post-transplant diabetes (PTDM). Notwithstanding the COVID-19 pandemic, transplantation rates are likely to grow, especially as the UK now has a “presumed consent” approach to organ donation. Furthermore, long-term follow-up of patients undergoing transplantation is increasingly managed in local district hospitals rather than in large transplant centres, and therefore many diabetes nurse specialists or primary care nurses may see patients with diabetes who have undergone organ transplantation. The new guidance from the Association of British Clinical Diabetologists and the Renal Association on prevention, detection and management of PTDM is, therefore, welcome.
In this short report, Tahseen Chowdhury reviews the new guidance.
